Cardiovascular Symptoms in Long COVID Linked to Endothelial and Cardiac Dysfunction via Dysregulation of the ADMA–DDAH–NOx Pathway - Report - MDSpire

Cardiovascular Symptoms in Long COVID Linked to Endothelial and Cardiac Dysfunction via Dysregulation of the ADMA–DDAH–NOx Pathway

  • By

  • Mohamed Saad Rakab

  • Imaduddin Mirza

  • Mohamed M. Ali

  • Ammar Khan

  • Dawood Darbar

  • Abeer M. Mahmoud

  • April 21, 2026

  • 0 min

Share

Clinical Report: Cardiovascular Symptoms in Long COVID Linked to Endothelial Dysfunction

Overview

This study identifies an imbalance in the ADMA–DDAH–NOx pathway associated with cardiovascular symptoms in long COVID. Participants with persistent symptoms exhibited significant endothelial dysfunction and cardiac involvement compared to controls.

Background

Post-acute sequelae of COVID-19 (PASC) is a significant public health issue, affecting 10%-20% of individuals post-infection. Cardiovascular manifestations are common and can indicate underlying endothelial and cardiac dysfunction, necessitating further investigation into their mechanisms for effective management.

Data Highlights

GroupD-dimerhs-CRPADMANOxEjection Fraction
PASC+High (>3-fold vs Controls)High (~3-fold vs Controls)HigherLowerLower
PASC−NormalNormalNormalNormalNormal
ControlsNormalNormalNormalNormalNormal

Key Findings

  • PASC+ individuals had significantly higher inflammatory markers compared to controls.
  • ADMA levels were substantially elevated in the PASC+ group, indicating impaired endothelial function.
  • Endothelial function, measured by flow-mediated dilation, was significantly lower in PASC+ participants.
  • PASC+ participants exhibited worse cardiac mechanics and higher levels of hs-troponin and NT-proBNP.
  • Ejection fraction was lower in PASC+ compared to both controls and PASC− groups.

Clinical Implications

The findings suggest that monitoring the ADMA–DDAH–NOx pathway may be beneficial for risk stratification in patients with long COVID. Clinicians should consider targeted interventions to address endothelial dysfunction in this population.

Conclusion

This study highlights the importance of the ADMA–DDAH–NOx axis in understanding cardiovascular symptoms in long COVID, suggesting potential avenues for therapeutic intervention.

References

  1. European Journal of Preventive Cardiology, 2023 -- Cardiovascular disease as part of Long COVID: a systematic review
  2. European Journal of Preventive Cardiology, 2023 -- Behind the shadows: bringing the cardiovascular secrets of long COVID into light
  3. The Pathologist, 2026 -- Is Long COVID Affecting the Heart?
  4. Infection, 2024 -- Endothelial Impairment and Cardiovascular Risk Assessment in Post-COVID-19 Individuals
  5. European Journal of Preventive Cardiology, 2026 -- Clinical consensus statement on COVID-19 cardiovascular management
  6. BMC Medicine, 2025 -- Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis
  7. Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC | European Journal of Preventive Cardiology | Oxford Academic
  8. Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis | BMC Medicine | Springer Nature Link

Original Source(s)

Related Content